20035-41-0

Basic information

• Product Name: 6-BROMO-2-HYDROXY-3-METHOXYBENZALDEHYDE
• Synonyms: 6-BROMO-2-HYDROXY-3-METHOXYBENZALDEHYDE;6-Bromo-2-hydroxy-2-methoxybenzaldehyde;6-BROMO-2-HYDROXY-3-METHOXYBENZALDEHYDE 99+%;2-Hydroxy-3-methoxy-6-bromobenzaldehyde;NSC95682
• CAS NO: 20035-41-0
• Molecular Formula: C₈H₇BrO₃
• Molecular Weight: 231.04
• Product Categories: Chemical Synthesis;Organic Building Blocks;Aldehydes;C8;Carbonyl Compounds;Building Blocks;Carbonyl Compounds
• Mol File: 20035-41-0.mol
• Article Data: 21

Chemical Properties

• Melting Point: 102-105 °C(lit.)
• Boiling Point: 282.1 °C at 760 mmHg
• Flash Point: 124.4 °C
• Appearance: /
• Density: 1.653 g/cm³
• Vapor Pressure: 0.00201mmHg at 25°C
• Refractive Index: 1.622
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 7.21±0.15(Predicted)
• CAS DataBase Reference: 6-BROMO-2-HYDROXY-3-METHOXYBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BROMO-2-HYDROXY-3-METHOXYBENZALDEHYDE(20035-41-0)
• EPA Substance Registry System: 6-BROMO-2-HYDROXY-3-METHOXYBENZALDEHYDE(20035-41-0)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 20035-41-0(Hazardous Substances Data)

Usage

Uses

6-Bromo-2-hydroxy-3-methoxybenzaldehyde may be used in the synthesis of:2-benzyloxy-6-bromo-3-methoxybenzaldehydebiphenylsantihypertensive natural products S-(+)-XJP and R-(-)-XJP

General Description

6-Bromo-2-hydroxy-3-methoxybenzaldehyde is a bromobenzaldehyde derivative. It participates in the synthesis of (±)-norannuradhapurine. Its crystals exhibit monoclinic crystal system and space group P21/n.

InChI:InChI=1/C8H7BrO3/c1-12-7-3-2-6(9)5(4-10)8(7)11/h2-4,11H,1H3

Upstream product

• 4885-02-3 Dichloromethyl methyl ether 
• 37942-01-1 5-bromo-2-methoxyphenol 
• 92252-86-3 1,1-diacetoxy-1-(2-acetoxy-3-methoxyphenyl)methane 
• 148-53-8 3-methoxy-2-hydroxybenzaldehyde 
• 159263-87-3 2-acetyloxy-3-methoxy-6-bromobenzaldehyde 
• 7150-01-8 2-acetoxy-3-methoxybenzaldehyde 

Downstream Products

• 64466-51-9 3,6-Dimethoxy-2-hydroxybenzaldehyde 
• 83983-71-5 6-bromo-2,3-dihydroxybenzaldehyde 
• 113250-72-9 2-benzyloxy-6-bromo-3-methoxybenzaldehyde 
• 1226513-68-3 isonicotinic acid (6-bromo-2-hydroxy-3-methoxybenzylidene)hydrazide 
• 1226513-69-4 cyanoacetic acid (6-bromo-2-hydroxy-3-methoxybenzylidene)hydrazide 
• 1226513-67-2 4-methyl-[1,2,3]thiadiazole-5-carboxylic acid (6-bromo-2-hydroxy-3-methoxybenzylidene)hydrazide 
• 148665-89-8 2,5-dimethoxy-6-heptadecylphenol 
• 148665-86-5 3-bromo-2-heptadecyl-6-methoxy-phenol 
• 290347-55-6 phosphoric acid dibenzyl ester 2-(bis-benzyloxy-phosphoryloxy)-6-methoxy-3-(3,4,5-trimethoxy-benzoyl)-phenyl ester 
• 290347-63-6 2',3'-Bis(methoxymethyloxy)-3,4,4',5-tetramethoxybenzophenone 
• 290347-54-5 2',3'-bis(methoxymethyloxy)-3,4,4',5-tetramethoxydiphenylcarbinol 
• 290347-52-3 (2',3'-dihydroxy-4'-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone 
• 290347-62-5 1-bromo-4-methoxy-2,3-bis(methoxymethoxy)-benzene 
• 590362-05-3 1-(3-benzyloxy-4-methoxy-2-triisopropylsilanyloxymethyl-phenyl)-3-isopropenyl-4-methyl-pent-3-en-1-ol 

Relevant articles and documents

Boron Containing PDE4 Inhibitors

The present invention relates to boron containing compounds of Formula (I) [in-line-formulae]X—Y—Z?? Formula (I)[/in-line-formulae] that inhibit phosphodiesterase 4 (PDE4). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating diseases, conditions, or disorders ameliorated by inhibition of PDE4.

Salvianolic acid A intermediate and preparation method thereof

The invention relates to a medicine salvianolic acid A intermediate used for treating angina and acute myocardial infarction, i.e., a new synthesis method for trans-3-bromo-2-(3,4-di-substituted styryl)-6-substituted phenol. The method comprises the follo

Atropoenantioselective redox-neutral amination of biaryl compounds through borrowing hydrogen and dynamic kinetic resolution

We report herein a novel atropoenantioselective redox-neutral amination of biaryl compounds triggered by a cascade of borrowing hydrogen and dynamic kinetic resolution under the cooperative catalysis of a chiral iridium complex and an achiral Br?nsted acid. This protocol features broad substrate scope and good functional-group tolerance, and allows the rapid assembly of axially chiral biaryl compounds in good to high yields and with high to excellent enantioselectivity.